HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Previous close
$0.40
Day range
$0.39 - $0.41
Year range
$0.31 - $0.70
Market cap
93.91M AUD
Avg Volume
180.24K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.47M | 191.69% |
Operating expense | 2.82M | 17.02% |
Net income | -3.87M | -3.66% |
Net profit margin | -111.36 | 64.46% |
Earnings per share | — | — |
EBITDA | -3.52M | 2.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.94M | -51.51% |
Total assets | 4.21M | -23.13% |
Total liabilities | 9.19M | 86.15% |
Total equity | -4.99M | — |
Shares outstanding | 231.87M | — |
Price to book | -20.00 | — |
Return on assets | -210.20% | — |
Return on capital | 3,591.39% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.87M | -3.66% |
Cash from operations | -3.46M | -6.24% |
Cash from investing | -203.96K | -190.87% |
Cash from financing | 2.43M | -46.62% |
Net change in cash | -1.24M | -201.00% |
Free cash flow | -2.22M | 3.70% |
About
CEO
Founded
Apr 11, 2007
Website
